New indication for AclastaNovartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. CFP announces new presidentPeter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). Clinical in Brief: Incidental findings common in cervical spine CTs YOUR TURN: The top medical absolutes PENSIONS: Canadian pension rules outdated Faculties of medicine creating clearer rules for pharma funding BAD ADVICE: Psychiatrists, don't shrink from sudoku Canada in brief Master deal mediation worth it, says NWTMA First Previous 2325 2326 2327 2328 2329 Next Last
